InsiderClue
Insiders · Profile

Dupont Jakob

Director at Pyxis Oncology · EVP, Head of R&D at Atara Biotherapeutics · Chief Medical Officer at Gossamer Bio. Filing since 27 Dec 2019. CIK 0001553335

PYXS Pyxis Oncology, Inc. Director · 1 trade ATRA Atara Biotherapeutics, Inc. EVP, Head of R&D · 12 trades GOSS Gossamer Bio, Inc. Chief Medical Officer · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PYXS Pyxis Oncology, Inc.
30 Jun 2026
Director
Sold on a plan
35,000
$107.10K
47.5%
ATRA Atara Biotherapeutics, Inc.
2 Mar 2023
EVP, Head of R&D
Sold, plan not stated
5,074
$18.40K
1.7%
ATRA Atara Biotherapeutics, Inc.
16 Nov 2022
EVP, Head of R&D
Sold, plan not stated
4,342
$19.50K
2.7%
ATRA Atara Biotherapeutics, Inc.
16 Aug 2022
EVP, Head of R&D
Sold, plan not stated
4,124
$20.76K
2.5%
ATRA Atara Biotherapeutics, Inc.
17 May 2022
EVP, Head of R&D
Sold, plan not stated
3,873
$20.60K
2.3%
ATRA Atara Biotherapeutics, Inc.
1 Mar 2022
EVP, Head of R&D
Sold, plan not stated
2,221
$21.89K
1.3%
ATRA Atara Biotherapeutics, Inc.
10 Feb 2022
EVP, Head of R&D
Sold, plan not stated
5,000
$80.00K
5.2%
ATRA Atara Biotherapeutics, Inc.
3 Jan 2022
EVP, Head of R&D
Sold, plan not stated
5,000
$80.05K
5.2%
ATRA Atara Biotherapeutics, Inc.
1 Dec 2021
EVP, Head of R&D
Sold, plan not stated
5,000
$89.69K
5.2%
ATRA Atara Biotherapeutics, Inc.
16 Nov 2021
EVP, Head of R&D
Sold, plan not stated
2,199
$37.64K
2.4%
ATRA Atara Biotherapeutics, Inc.
2 Nov 2021
EVP, Head of R&D
Sold, plan not stated
5,000
$82.05K
5.1%
ATRA Atara Biotherapeutics, Inc.
17 Aug 2021
EVP, Head of R&D
Sold, plan not stated
2,152
$26.97K
2.3%
ATRA Atara Biotherapeutics, Inc.
18 May 2021
EVP, Head of R&D
Sold, plan not stated
5,184
$75.43K
5.2%
GOSS Gossamer Bio, Inc.
30 Dec 2019
Chief Medical Officer
Sold, plan not stated
40,000
$600.00K
100%
GOSS Gossamer Bio, Inc.
27 Dec 2019
Chief Medical Officer
Sold, plan not stated
1,994
$31.53K
100%
15 decisions on file.